ASH: Glofitamab Aids Relapsed, Refractory Diffuse Large B-Cell Lymphoma
MONDAY, Dec. 19, 2022 (HealthDay News) — The bispecific antibody that recruits T cells to tumor cells, glofitamab, is effective for patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), according to a study published online Dec….
Learn MoreBacteria From Oral Cavity ID’d in Brain Abscess Without Clear Cause
MONDAY, Dec. 19, 2022 (HealthDay News) — Bacteria usually found in the oral cavity are often found in cases of brain abscess where no clear cause has been identified, according to a study published in the January issue of the Journal of Dentistry.Hol…
Learn MoreFDA Approves Gene Therapy for Tough-to-Treat Bladder Cancer
MONDAY, Dec. 19, 2022 (HealthDay News) — Patients with a high-risk bladder cancer now have a new option to treat it.The U.S. Food and Drug Administration on Friday approved a gene therapy called Adstiladrin, which is designed to work for patients who…
Learn MoreMany U.S. Women Must Travel Far to Get Mammograms
MONDAY, Dec. 19, 2022 (HealthDay News) — Many American women have to travel long distances to reach the nearest mammography center, a new study finds — raising questions about whether that keeps some from receiving breast cancer screening.Researcher…
Learn MoreRace Could Affect Outcomes in Head-and-Neck Cancers
MONDAY, Dec. 19, 2022 (HealthDay News) — Black patients with head-and-neck cancers have twice the death rates of white patients, and a new study suggests race itself underlies those differences.“What is unique about our study is it strongly supports …
Learn MoreLifestyle May Counter Genetic Risk for Thyroid Cancer
FRIDAY, Dec. 16, 2022 (HealthDay News) — Genetic and lifestyle factors are independently associated with incident thyroid cancer, according to a study published online Dec. 12 in JAMA Network Open.Xiuming Feng, from Guangxi Medical University in Nann…
Learn MoreLos estadounidenses podrían tener más probabilidades de sufrir Parkinson de lo que se pensaba
JUEVES, 15 de diciembre de 2022 (HealthDay News) — La enfermedad de Parkinson es un problema mucho más grande de lo que se pensaba, sobre todo para los estadounidenses mayores, encuentra un nuevo estudio.Cada año, en Norteamérica se diagnostican alre…
Learn MoreGlobal Inequalities Remain in Cervical Cancer Incidence
FRIDAY, Dec. 16, 2022 (HealthDay News) — Substantial geographic and socioeconomic inequalities are seen in cervical cancer globally, according to a study published online Dec. 14 in The Lancet Global Health.Deependra Singh, Ph.D., from the World Heal…
Learn MoreLight Therapy Might Ease MS-Related Fatigue
FRIDAY, Dec. 16, 2022 (HealthDay News) — Extreme fatigue often tops the list of the most distressing symptoms for millions of people who live with multiple sclerosis (MS).And now, a new study suggests that light therapy may help these folks get their…
Learn MoreJane Fonda Says Her Lymphoma Is in Remission
FRIDAY, Dec. 16, 2022 (HealthDay News) – Actress and two-time Academy Award winner Jane Fonda announced Thursday that her non-Hodgkin lymphoma is in remission.Fonda, 84, said in a blog post that she can quit chemotherapy treatments, calling it the “BE…
Learn More